MedPath

Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care

Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
Other: quality-of-life assessment
Registration Number
NCT00045019
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Brief Summary

RATIONALE: Questionnaires may help determine cancer patients' satisfaction with the quality of care they received in the hospital.

PURPOSE: Clinical trial to determine the effectiveness of questionnaires in assessing cancer patients' satisfaction with the quality of care they received in the hospital.

Detailed Description

OBJECTIVES:

* Determine the scale structure, reliability, and validity of the QLQ-SAT32 patient satisfaction module in assessing the perception of the quality of care received in hospitals by patients with cancer.

* Determine the success of the QLQ-SAT32 patient satisfaction module when used with the QLQ-C30 core quality of life questionnaire, in terms of expanding on quality of life evaluation or providing information on treatment acceptability or preference of these patients.

OUTLINE: This is a descriptive, multicenter study. Patients are stratified according to age (18 to 49 vs 50 and over) and the cancer therapy received in hospital (surgery vs chemotherapy).

Patients in all strata receive the QLQ-SAT32 and QLQ-C30 questionnaires, a debriefing questionnaire, and the Oberst patient satisfaction visual analog scale prior to hospital discharge. Patients complete the materials at home within 7 days of discharge. A group of 100 patients have a repeat QLQ-SAT32 module mailed to them to be completed within 7 days of receipt of first questionnaire.

PROJECTED ACCRUAL: A total of 640-768 patients (160-192 per stratum) will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
795
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
discharged cancer patientsquality-of-life assessmentpatients discharged from a surgery or medical ward of oncology institutes in Belgium, France, Germany, Italy, Poland, Spain, Sweden, Taiwan and United Kingdom (as part of a larger psychometric validation study) were asked to rate there level of satisfaction, using the EORTC QLQ-SAT32.
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (11)

Sahlgrenska University Hospital

πŸ‡ΈπŸ‡ͺ

Gothenburg, Sweden

Institut Curie - Section Medicale

πŸ‡«πŸ‡·

Paris, France

Centre Paul Strauss

πŸ‡«πŸ‡·

Strasbourg, France

Centre Regional Francois Baclesse

πŸ‡«πŸ‡·

Caen, France

Uppsala University Hospital

πŸ‡ΈπŸ‡ͺ

Uppsala, Sweden

Bristol Royal Infirmary

πŸ‡¬πŸ‡§

Bristol, United Kingdom

Hospital De Navarra

πŸ‡ͺπŸ‡Έ

Pamplona, Spain

Institut Bergonie

πŸ‡«πŸ‡·

Bordeaux, France

Centre Alexis Vautrin

πŸ‡«πŸ‡·

Vandoeuvre-les-Nancy, France

Institut Gustave Roussy

πŸ‡«πŸ‡·

Villejuif, France

Institut Jules Bordet

πŸ‡§πŸ‡ͺ

Brussels, Belgium

Β© Copyright 2025. All Rights Reserved by MedPath